NDC 15631-0090

CALADIUM SEGUINUM

Caladium Seguinum

CALADIUM SEGUINUM is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Dieffenbachia Seguine.

Product ID15631-0090_092b8d34-0044-4b6f-8c7f-37defe4aba70
NDC15631-0090
Product TypeHuman Otc Drug
Proprietary NameCALADIUM SEGUINUM
Generic NameCaladium Seguinum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-09-12
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameDIEFFENBACHIA SEGUINE
Active Ingredient Strength3 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0090-0

100 PELLET in 1 PACKAGE (15631-0090-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0090-0 [15631009000]

CALADIUM SEGUINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0090-3 [15631009003]

CALADIUM SEGUINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0090-1 [15631009001]

CALADIUM SEGUINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0090-2 [15631009002]

CALADIUM SEGUINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0090-4 [15631009004]

CALADIUM SEGUINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0090-5 [15631009005]

CALADIUM SEGUINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

Drug Details

Active Ingredients

IngredientStrength
DIEFFENBACHIA SEGUINE3 [hp_X]/1

OpenFDA Data

SPL SET ID:93deab6c-fe95-46f4-8439-5d288438db72
Manufacturer
UNII

NDC Crossover Matching brand name "CALADIUM SEGUINUM" or generic name "Caladium Seguinum"

NDCBrand NameGeneric Name
0220-1027Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1031Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1032Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1034Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1035Caladium seguinumDIEFFENBACHIA SEGUINE
0220-1036Caladium seguinumDIEFFENBACHIA SEGUINE
15631-0090CALADIUM SEGUINUMCALADIUM SEGUINUM
15631-0546CALADIUM SEGUINUMCALADIUM SEGUINUM
63545-622Caladium SeguinumCaladium Seguinum
63545-623Caladium SeguinumCaladium Seguinum
63545-624Caladium SeguinumCaladium Seguinum
63545-625Caladium SeguinumCaladium Seguinum
63545-626Caladium SeguinumCaladium Seguinum
63545-627Caladium SeguinumCaladium Seguinum
63545-628Caladium SeguinumCaladium Seguinum
63545-629Caladium SeguinumCaladium Seguinum
68428-271Caladium SeguinumDIEFFENBACHIA SEGUINE
71919-141Caladium seguinumDIEFFENBACHIA SEGUINE
69152-1166Caladium seguinum 200CCaladium seguinum

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.